These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7166914)
1. Serial determinations of carcinoembryonic antigen for early detection of recurrent gastric cancer. Tamada R; Hiramoto Y; Abe Y; Nouzuka T; Okamura T; Masuda H; Kano T; Kumashiro R; Inokuchi K Jpn J Surg; 1982; 12(6):429-33. PubMed ID: 7166914 [TBL] [Abstract][Full Text] [Related]
2. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Qiu MZ; Lin JZ; Wang ZQ; Wang FH; Pan ZZ; Luo HY; Li YH; Zhou ZW; He YJ; Xu RH Int J Biol Markers; 2009; 24(4):258-64. PubMed ID: 20082274 [TBL] [Abstract][Full Text] [Related]
3. Serum CEA levels facilitate detection of recurrences of cancer in patients after gastrectomy. Tamada R; Hiramoto Y; Tsujitani S; Nozuka T; Okamura T; Masuda H; Sugimachi K; Inokuchi K Jpn J Surg; 1985 Jan; 15(1):23-9. PubMed ID: 2985853 [TBL] [Abstract][Full Text] [Related]
4. The usefulness of CEA as an indicator for early detection and a guide to the treatment of recurrent gastric cancer. Kano T; Koga T; Souda K; Abe Y; Yonemura T; Oka N; Inokuchi K Jpn J Surg; 1987 Jul; 17(4):269-75. PubMed ID: 3682435 [TBL] [Abstract][Full Text] [Related]
5. Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy. Uda H; Kanda M; Tanaka C; Kobayashi D; Inaoka K; Tanaka Y; Hayashi M; Iwata N; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y Dig Surg; 2018; 35(1):55-63. PubMed ID: 28441659 [TBL] [Abstract][Full Text] [Related]
6. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
8. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas. Umehara Y; Kimura T; Yoshida M; Oba N; Harada Y Cancer; 1993 Jun; 71(12):4055-9. PubMed ID: 8508370 [TBL] [Abstract][Full Text] [Related]
9. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Takahashi Y; Takeuchi T; Sakamoto J; Touge T; Mai M; Ohkura H; Kodaira S; Okajima K; Nakazato H; Gastric Cancer; 2003; 6(3):142-5. PubMed ID: 14520526 [TBL] [Abstract][Full Text] [Related]
10. Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer. Tas F; Faruk Aykan N; Aydiner A; Yasasever V; Topuz E Am J Clin Oncol; 2001 Apr; 24(2):148-9. PubMed ID: 11319289 [TBL] [Abstract][Full Text] [Related]
11. [Value of radioimmunological serum levels of carcinoembryonic antigen in the postoperative monitoring of rectocolonic cancer]. Reginster JY; Desaive C; Collette J; Zangerle PF; Denis D; Franchimont P Ann Gastroenterol Hepatol (Paris); 1984; 20(4):203-6. PubMed ID: 6529177 [TBL] [Abstract][Full Text] [Related]
12. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer. Fernandes LC; Kim SB; Saad SS; Matos D World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977 [TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen in gastric cancer patients. Shimizu N; Wakatsuki T; Murakami A; Yoshioka H; Hamazoe R; Kanayama H; Maeta M; Koga S Oncology; 1987; 44(4):240-4. PubMed ID: 3614814 [TBL] [Abstract][Full Text] [Related]
14. [Stomach adenocarcinomas: comparison between CA 19-9 and carcinoembryonic antigen for the diagnosis of recurrences after surgical treatment]. Ychou M; Tuszinski T; Pignon JP; Bidart JM; Bellet D; Bohuon C; Rougier P Gastroenterol Clin Biol; 1992; 16(11):848-52. PubMed ID: 1483553 [TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen in patients with gastric carcinoma. Janssen CW; Orjasaeter H Eur J Surg Oncol; 1986 Mar; 12(1):19-23. PubMed ID: 3956751 [TBL] [Abstract][Full Text] [Related]
16. Tissue polypeptide-specific antigen and carcinoembryonic antigen for early prediction of recurrence in lung adenocarcinoma. Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH Am J Clin Oncol; 2000 Dec; 23(6):605-8. PubMed ID: 11202807 [TBL] [Abstract][Full Text] [Related]
17. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study. Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781 [TBL] [Abstract][Full Text] [Related]
18. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Wood CB; Ratcliffe JG; Burt RW; Malcolm AJ; Blumgart LH Br J Surg; 1980 Jan; 67(1):46-8. PubMed ID: 7357243 [TBL] [Abstract][Full Text] [Related]
19. [The use of CEA radioimmunoassay for the detection of recurrence of carcinoma of the large bowel (author's transl)]. Jaquet H; Mach JP; Pettavel J Langenbecks Arch Chir; 1976 Nov; 342():243-9. PubMed ID: 994637 [TBL] [Abstract][Full Text] [Related]
20. The use of serial carcinoembryonic antigen determinations to predict recurrence of carcinoma of the colon and the time for a second-look operation. Minton JP; James KK; Hurtubise PE; Rinker L; Joyce S; Martin EW Surg Gynecol Obstet; 1978 Aug; 147(2):208-10. PubMed ID: 684571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]